BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 22298894)

  • 21. Introduction. Personalizing patient care with precision medicine.
    Wujcik D; Knoop T
    Semin Oncol Nurs; 2014 May; 30(2):81-3. PubMed ID: 24794081
    [No Abstract]   [Full Text] [Related]  

  • 22. The biggest challenges currently facing companion diagnostic advancement.
    Halim AB
    Expert Rev Mol Diagn; 2014 Jan; 14(1):27-35. PubMed ID: 24308333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biospecimen banking: the pathway to personalized medicine for patients with cancer.
    Scolyer RA; Thompson JF
    J Surg Oncol; 2013 Jun; 107(7):681-2. PubMed ID: 23280671
    [No Abstract]   [Full Text] [Related]  

  • 24. The search for optimal response prediction in cancer leads to a personalized approach.
    Van Cutsem E; Ciardiello F
    Target Oncol; 2010 Mar; 5(1):3-4. PubMed ID: 20349283
    [No Abstract]   [Full Text] [Related]  

  • 25. US FDA perspective on challenges in co-developing in vitro companion diagnostics and targeted cancer therapeutics.
    Philip R; Carrington L; Chan M
    Bioanalysis; 2011 Feb; 3(4):383-9. PubMed ID: 21338257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional drug-gene interactions in lung cancer.
    Smida M; Nijman SM
    Expert Rev Mol Diagn; 2012 Apr; 12(3):291-302. PubMed ID: 22468819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular markers in the treatment of metastatic colorectal cancer.
    Wilson PM; Labonte MJ; Lenz HJ
    Cancer J; 2010; 16(3):262-72. PubMed ID: 20526105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenges of cancer biomarker profiling.
    Bensalah K; Montorsi F; Shariat SF
    Eur Urol; 2007 Dec; 52(6):1601-9. PubMed ID: 17919807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Refocusing the war on cancer: the critical role of personalized treatment.
    Potti A; Schilsky RL; Nevins JR
    Sci Transl Med; 2010 Apr; 2(28):28cm13. PubMed ID: 20410527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Personalized medicine in oncology: tailoring the right drug to the right patient.
    Jiang Y; Wang M
    Biomark Med; 2010 Aug; 4(4):523-33. PubMed ID: 20701441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early phase clinical trials in pediatric hematology and oncology.
    Corbacioglu S
    Klin Padiatr; 2012 Apr; 224(3):197-200. PubMed ID: 22511313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Translational research: precision medicine, personalized medicine, targeted therapies: marketing or science?
    Marquet P; Longeray PH; Barlesi F; ; Ameye V; Augé P; Cazeneuve B; Chatelut E; Diaz I; Diviné M; Froguel P; Goni S; Gueyffier F; Hoog-Labouret N; Mourah S; Morin-Surroca M; Perche O; Perin-Dureau F; Pigeon M; Tisseau A; Verstuyft C
    Therapie; 2015; 70(1):1-19. PubMed ID: 25679189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Research and development for cancer biomarker].
    Nakagawa H
    Nihon Rinsho; 2012 May; 70(5):743-7. PubMed ID: 22619995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Personalized medicine in the treatment of advanced nonsmall cell lung cancer: step-by-step progress.
    Gridelli C
    Curr Opin Oncol; 2012 Mar; 24(2):115-6. PubMed ID: 22123236
    [No Abstract]   [Full Text] [Related]  

  • 35. Cancer drugs find a companion with new diagnostic tests.
    Schubert C
    Nat Med; 2011 Oct; 17(10):1157. PubMed ID: 21988963
    [No Abstract]   [Full Text] [Related]  

  • 36. Personalized network-based treatments in oncology.
    Robin X; Creixell P; Radetskaya O; Santini CC; Longden J; Linding R
    Clin Pharmacol Ther; 2013 Dec; 94(6):646-50. PubMed ID: 23995267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular targeted therapy for cancer].
    Sone S; Kuramoto T; Sato S; Mitsuhashi A; Kakiuchi S; Goto H; Tada H; Nishioka Y
    Nihon Rinsho; 2010 Jun; 68(6):997-1006. PubMed ID: 20535947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive medicine: incipient reality or fata morgana?
    Dietel M
    J Pathol; 2007 Aug; 212(4):353-5. PubMed ID: 17573671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular medicine and the development of cancer chemopreventive agents.
    Izzotti A
    Ann N Y Acad Sci; 2012 Jul; 1259():26-32. PubMed ID: 22758633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential of circulating nucleic acids as components of companion diagnostics for predicting and monitoring chemotherapy response.
    Schwarzenbach H
    Expert Rev Mol Diagn; 2015 Feb; 15(2):267-75. PubMed ID: 25382372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.